首頁 > 市場調查報告書 > 製藥

處方藥疼痛

市場調查報告書

商品編碼

1550583

全球非處方止痛藥市場：依藥物類別、給藥途徑、劑型、通路及地區分類

Over The Counter Pain Medication Market, By Drug Class (Non-steroidal Anti-inflammatory Drugs, Local Anaesthetics, Acetaminophen, Salicylates, Others), By Route of Administration, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2024年08月02日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球非處方止痛藥市場規模預計將從 2024 年的 271.2 億美元增至 2031 年的 355 億美元，2024 年至 2031 年複合年成長率為 3.9%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	271.2億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	3.90%	2031年價值預測	355億美元

圖：2024 年非處方止痛藥市佔率（按地區分類）

由於關節炎、下背痛和其他肌肉骨骼疾病等健康狀況的盛行率不斷上升，全球非處方止痛藥市場在過去十年中出現了顯著成長。容易取得的非處方箋止痛藥以及人們越來越傾向於自我治療而不是看醫生正在推動市場成長。此外，已開發國家人口老化，更容易受到慢性疼痛的影響，需求也增加。各種製藥公司正在透過推出功效更高、副作用最小的新產品來開拓利潤豐厚的前景。

市場動態：

全球非處方止痛藥市場的主要驅動力是老年人口的增加、文明病患者數量的增加以及不需要即時醫療干預的輕傷和不適症狀的數量增加。然而，特別是在已開發國家，圍繞自我治療的法律規範非常嚴格，為企業的順利運作帶來了挑戰。此外，替代傳統止痛療法的可用性也在一定程度上阻礙了市場的成長。同時，發展中地區健康意識的提高和電子商務的普及正在開拓新的收益來源。此外，先進藥物輸送系統的持續研究和開發正在為市場創造新的機會。

本研究的主要特點

該報告對全球非處方止痛藥市場進行了詳細分析，並以2023年為基準年估計了預測期內（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）發布了。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

基於公司亮點、產品系列、主要亮點、財務表現和策略等參數的全球非處方止痛藥市場的主要企業概況。

主要企業包括強生、輝瑞、拜耳、GlaxoSmithKline Plc、大正製藥和雀巢。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球非處方止痛市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球非處方止痛市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Johnson &Johnson
- Pfizer Inc.
- Bayer AG
- GlaxoSmithKline plc
- Sanofi SA
- Reckitt Benckiser Group plc
- Novartis AG
- Perrigo Company plc
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Limited
- Aurobindo Pharma Limited

第11章分析師建議

Wheel of Fortune
分析師觀點
Coherent Opportunity Map（COM）

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7222

The global over the counter pain medication market is estimated to be valued at USD 27.12 Bn in 2024 and is expected to reach USD 35.50 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 27.12 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	3.90%	2031 Value Projection:	US$ 35.50 Bn

Figure. Over The Counter Pain Medication Market Share (%), By Region 2024

Over The Counter Pain Medication Market - IMG1

The global over the counter pain medication market has witnessed substantial growth over the past decade owing to rising incidence of health conditions such as arthritis, back pain, and other muscular skeletal disorders across the world. Easy availability of pain relief drugs without prescription coupled with growing preference for self-medication over doctor visits has boosted the market growth. Furthermore, aging population profile in developed nations which are more vulnerable to chronic pain has augmented demand. Various pharmaceutical companies are launching new products with improved efficacy and minimal side effects to tap the lucrative prospects.

Market Dynamics:

The global over the counter pain medication market is primarily driven by rising geriatric population base, increasing prevalence of lifestyle induced diseases, and growing instances of minor injuries and discomforts which do not require immediate medical intervention. However, stringent regulatory framework surrounding self-medication especially in developed countries poses challenge to smooth business operations. Moreover, availability of alternative traditional pain relief therapies also impedes the market growth to some extent. On the bright side, growing health awareness and e-commerce penetration in developing regions have opened new revenue streams. Ongoing research & development towards developing advanced drug delivery systems is creating novel opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global over-the-counter pain medication market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global over-the-counter pain medication market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson, Pfizer, Bayer, GlaxoSmithKline, Taisho Pharmaceuticals, and Nestle

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global over-the-counter pain medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over-the-counter pain medication market.

Detailed Segmentation

By Drug Class
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Local Anaesthetics
- Acetaminophen
- Salicylates
- Others
By Route of Administration
- Oral
- Topical
- Others
By Dosage Form
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Johnson & Johnson
- Pfizer Inc.
- Bayer AG
- GlaxoSmithKline plc
- Sanofi S.A.
- Reckitt Benckiser Group plc
- Novartis AG
- Perrigo Company plc
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Cipla Ltd.
- Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Limited
- Aurobindo Pharma Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Over The Counter Pain Medication Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Over The Counter Pain Medication Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Local Anaesthetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Acetaminophen
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Salicylates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Over The Counter Pain Medication Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Over The Counter Pain Medication Market, By Dosage Form, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Tablets/Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liquids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Creams
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gels
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Over The Counter Pain Medication Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Over The Counter Pain Medication Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
Asia Pacific
Middle East

10. Competitive Landscape

Company Profiles
- Johnson & Johnson
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
- Bayer AG
- GlaxoSmithKline plc
- Sanofi S.A.
- Reckitt Benckiser Group plc
- Novartis AG
- Perrigo Company plc
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Limited
- Aurobindo Pharma Limited